Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleNuclear Oncology

In Vivo Detection of Malignant Thymic Masses by Indiium-111-DTPA-D-Phe1-Octreotide Scintigranhy

Secondo Lastoria, Emilia Vergara, Giovannella Palmieri, Wanda Acampa, Paola Varrella, Corradina Caracò, Raffaele A. Bianco, Pietro Muto and Marco Salvatore
Journal of Nuclear Medicine April 1998, 39 (4) 634-639;
Secondo Lastoria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emilia Vergara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giovannella Palmieri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wanda Acampa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paola Varrella
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corradina Caracò
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raffaele A. Bianco
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pietro Muto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Salvatore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 39, Issue 4
April 1, 1998
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
In Vivo Detection of Malignant Thymic Masses by Indiium-111-DTPA-D-Phe1-Octreotide Scintigranhy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
In Vivo Detection of Malignant Thymic Masses by Indiium-111-DTPA-D-Phe1-Octreotide Scintigranhy
Secondo Lastoria, Emilia Vergara, Giovannella Palmieri, Wanda Acampa, Paola Varrella, Corradina Caracò, Raffaele A. Bianco, Pietro Muto, Marco Salvatore
Journal of Nuclear Medicine Apr 1998, 39 (4) 634-639;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
In Vivo Detection of Malignant Thymic Masses by Indiium-111-DTPA-D-Phe1-Octreotide Scintigranhy
Secondo Lastoria, Emilia Vergara, Giovannella Palmieri, Wanda Acampa, Paola Varrella, Corradina Caracò, Raffaele A. Bianco, Pietro Muto, Marco Salvatore
Journal of Nuclear Medicine Apr 1998, 39 (4) 634-639;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Thymic Malignancies: From Clinical Management to Targeted Therapies
  • Thymoma: Benign Appearance, Malignant Potential
  • Conditions Suggesting Lymphoma: CASE 2. Mediastinal Liposarcoma in a Patient With Previous Testicular Cancer
  • Octreotide Alone or With Prednisone in Patients With Advanced Thymoma and Thymic Carcinoma: An Eastern Cooperative Oncology Group Phase II Trial
  • Google Scholar

More in this TOC Section

  • Response to Treatment with Yttrium 90-DOTA-Lanreotide of a Patient with Metastatic Gastrinoma
  • Flare Response Seen in Therapy for Osteomalacia
  • Dose Escalation Trial of Indium-111-Labeled Anti-Carcinoembryonic Antigen Chimeric Monoclonal Antibody (Chimeric T84.66) in Presurgical Colorectal Cancer Patients
Show more Nuclear Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire